The FDA is looking at whether the diabetes drug Avandia should stay on the market.
Avandia used to be one of GlaxoSmithKline's best-selling drugs, but studies have linked it to an increased risk of heart attack.
Government scientists have said the company's own study to demonstrate the drug's safety is "seriously flawed."
A panel of outside experts will recommend if Avandia needs a stronger warning label or to be pulled from the market.
Viewers with disabilities can get assistance accessing this station's FCC Public Inspection File by contacting the station with the information listed below. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, 888-835-5322 (TTY), or email@example.com.